Add to My Stocks
$3.27 $0.26 (7.37%) ATXI stock closing price Sep 19, 2018 (Closing)

The AVENUE THERAPTC cash flow statement helps investors understand how well the company is managing its cash flows. This report provides details about cash inflows and outflows due to the company's business and investment activities, and summarize cash outflows for a given quarter. For AVENUE THERAPTC profits one has to check the income statement and for AVENUE THERAPTC debt one has to check the balance sheet. This statement can tell if a company is running out of money while still being profitable and is useful in AVENUE THERAPTC stock analysis. AVENUE THERAPTC had a negative net income cash flow of $-15.03M till this quarter of 2018 Q2. This report is very useful in measuring the short term viability of a company. The cash from operating activities for AVENUE THERAPTC is $ 2018 Q2, which saw a decrease from previous quarter.

View and download details of AVENUE THERAPTC cash flows for latest & last 40 quarters
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q2
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow---------
Net Increase (Decrease) in Assets Liabilities1.52M3.2M2.07M1.53M--1.08M--
Cash From (used in) Discontinued Operations---------
Other Adjustments Net--3.2M1.76M1.52M----
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment---------
Acquisition Disposition of Subsidiaires---------
Increase (Decrease) in Investments10M10M-10M-10M-----
Other Cash Inflow (Outflow) from Investment Activities---------
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares--37.95M37.95M37.95M---0.01M-
Issuance (Repayment) of Debt Securities---3M-3M-----
Increase (Decrease) in Bank & Other Borrowings---2.84M-2.84M--1.67M1.58M1.13M
Payment of Dividends & Other Cash Distributions---------
Other Cash from (used by) Financing Activities---3.71M-3.71M-3.44M-0.23M-0.05M--
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash---------
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year11.78M--------
Cash & Equivalents at Year End8.94M14.96M11.78M16.05M34.68M----
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

While AVENUE THERAPTC stock price history provides the price history of a stock, AVENUE THERAPTC stock comparison chart shows the same in comparison to peers, and cash flow statements provide cash position of the company. Common terms used in the statement of cash flows are:

  • AVENUE THERAPTC saw a negative change in Net Change in Cash and Cash Equivalents of $-2.84M till 2018 Q2. Apart from the AVENUE THERAPTC stock price, this is one of the things an investor looks for, as it shows the net change in cash on hand for a company, compared to previous period.
  • AVENUE THERAPTC decreased its cash from operating activities to $-12.84M till 2018 Q2. Operating activities include production of goods or creating a product or providing a service, and collecting payment for the same from customers. The cash generated from these activities is refered to as cash flow from operating activities.
  • Cash Flow from investment activities: AVENUE THERAPTC generated $10M cash due to investment activities. It includes the use of cash outside of normal day to day activities like buying fixed assets, plant and machinery etc.
  • Cash Flow from financing activities: Financing activities include the cash that comes into a company in the form of loans or interest earned or shareholders money, as well as the cash that goes out. AVENUE THERAPTC spent $- from financing activities,in the form of repayment of loans or interest paid, dividend pay-out to shareholders etc.

Key Financial Ratios For AVENUE THERAPTC Cash Flow

Quarterly Cash Flow Statements For AVENUE THERAPTC Peers

AIT THERAPEUTIC cash flow, Biomerica cash flow, Lipocine cash flow, ProPhase Labs cash flow